Intuitive Surgical (NASDAQ:ISRG) had its target price raised by equities research analysts at Raymond James from $610.00 to $625.00 in a research note issued to investors on Friday, The Fly reports. Raymond James’ target price would indicate a potential upside of 10.26% from the company’s previous close.
Other analysts have also issued reports about the stock. Redburn Partners began coverage on shares of Intuitive Surgical in a research note on Friday, September 13th. They set a “buy” rating for the company. BidaskClub downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, September 11th. Piper Jaffray Companies upped their target price on Intuitive Surgical from $610.00 to $633.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Canaccord Genuity reiterated a “buy” rating and issued a $610.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Friday, July 19th. Finally, Cantor Fitzgerald set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a report on Friday, July 19th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $579.08.
NASDAQ ISRG traded up $37.42 on Friday, reaching $566.82. The company’s stock had a trading volume of 174,115 shares, compared to its average volume of 567,611. Intuitive Surgical has a twelve month low of $430.24 and a twelve month high of $589.32. The stock has a market cap of $60.88 billion, a PE ratio of 59.73, a PEG ratio of 3.88 and a beta of 1.13. The firm’s 50 day moving average is $520.62 and its two-hundred day moving average is $517.36.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $3.43 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.99 by $0.44. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.35%. The company had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the company earned $2.83 EPS. Intuitive Surgical’s revenue was up 22.5% on a year-over-year basis. As a group, sell-side analysts anticipate that Intuitive Surgical will post 10.12 EPS for the current fiscal year.
In other Intuitive Surgical news, VP Jamie Samath sold 130 shares of the firm’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $503.50, for a total transaction of $65,455.00. Following the transaction, the vice president now owns 219 shares in the company, valued at $110,266.50. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Lonnie M. Smith sold 215 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $493.18, for a total value of $106,033.70. Following the transaction, the director now owns 330,868 shares in the company, valued at approximately $163,177,480.24. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 25,869 shares of company stock valued at $13,664,252. 1.70% of the stock is owned by company insiders.
A number of institutional investors and hedge funds have recently modified their holdings of ISRG. Manchester Financial Inc. bought a new stake in Intuitive Surgical in the 2nd quarter valued at $25,000. Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its stake in Intuitive Surgical by 733.3% in the 2nd quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 66 shares during the period. North Star Investment Management Corp. bought a new stake in Intuitive Surgical in the 3rd quarter valued at $49,000. FNY Investment Advisers LLC bought a new stake in Intuitive Surgical in the 2nd quarter valued at $47,000. Finally, Motco bought a new stake in Intuitive Surgical in the 2nd quarter valued at $51,000. Hedge funds and other institutional investors own 85.90% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Read More: What is meant by holder of record?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.